Literature DB >> 24780757

Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.

Francesca Bruzzese1, Christina Hägglöf2, Alessandra Leone1, Elin Sjöberg3, Maria Serena Roca1, Sara Kiflemariam4, Tobias Sjöblom4, Peter Hammarsten2, Lars Egevad3, Anders Bergh2, Arne Ostman3, Alfredo Budillon1, Martin Augsten5.   

Abstract

The tumor stroma is vital to tumor development, progression, and metastasis. Cancer-associated fibroblasts (CAF) are among the abundant cell types in the tumor stroma, but the range of their contributions to cancer pathogenicity has yet to be fully understood. Here, we report a critical role for upregulation of the TGFβ/BMP family member GDF15 (MIC-1) in tumor stroma. GDF15 was found upregulated in situ and in primary cultures of CAF from prostate cancer. Ectopic expression of GDF15 in fibroblasts produced prominent paracrine effects on prostate cancer cell migration, invasion, and tumor growth. Notably, GDF15-expressing fibroblasts exerted systemic in vivo effects on the outgrowth of distant and otherwise indolent prostate cancer cells. Our findings identify tumor stromal cells as a novel source of GDF15 in human prostate cancer and illustrate a systemic mechanism of cancer progression driven by the tumor microenvironment. Further, they provide a functional basis to understand GDF15 as a biomarker of poor prognosis and a candidate therapeutic target in prostate cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24780757     DOI: 10.1158/0008-5472.CAN-13-2259

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

2.  Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.

Authors:  Mingyang Song; Raaj S Mehta; Kana Wu; Charles S Fuchs; Shuji Ogino; Edward L Giovannucci; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-28

Review 3.  Cancer-associated fibroblasts: how do they contribute to metastasis?

Authors:  Mei Qi Kwa; Kate M Herum; Cord Brakebusch
Journal:  Clin Exp Metastasis       Date:  2019-03-07       Impact factor: 5.150

Review 4.  Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients.

Authors:  Anna Spanopoulou; Vasiliki Gkretsi
Journal:  Clin Exp Metastasis       Date:  2020-06-05       Impact factor: 5.150

Review 5.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

6.  GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.

Authors:  Naoki Urakawa; Soken Utsunomiya; Mari Nishio; Manabu Shigeoka; Nobuhisa Takase; Noriaki Arai; Yoshihiro Kakeji; Yu-ichiro Koma; Hiroshi Yokozaki
Journal:  Lab Invest       Date:  2015-03-02       Impact factor: 5.662

Review 7.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

8.  Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior.

Authors:  Ilaria Giusti; Marianna Di Francesco; Sandra D'Ascenzo; Maria Grazia Palmerini; Guido Macchiarelli; Gaspare Carta; Vincenza Dolo
Journal:  Cancer Biol Ther       Date:  2018-04-25       Impact factor: 4.742

Review 9.  Parallels between wound healing, epimorphic regeneration and solid tumors.

Authors:  Alan Y Wong; Jessica L Whited
Journal:  Development       Date:  2020-01-02       Impact factor: 6.868

Review 10.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.